The Karen Wyckoff Rein in Sarcoma Foundation announced three recipients of their 2019 Sarcoma Research Grants. This is the 19th year that the Karen Wyckoff Rein in Sarcoma Foundation has provided grants to the University of Minnesota, with this year's contribution totaling $150,000.
Awardees for 2019 and their research are:
Masato Yamamoto, PhD - MYOG Promoter-Controlled Oncolytic Adenovirus to Treat PAX3-FOXO1- Positive Rhabdomyosarcoma
Each year the Randy Shaver Cancer Research & Community Fund awards grants to groups across the state of Minnesota that are working to reduce the burden of cancer.
The mission of the Randy Shaver Cancer Research and Community Fund is to support the cancer community in Minnesota by funding research, prevention, treatment and other programs relating to the cancer community’s needs.
Media and Public Relations Manager
University of Minnesota Medical School
“Fourteen years ago I was diagnosed with stage 1 testicular cancer,” said Scott Petinga. “Everyone said it was the best kind you can get — since it had a survivor rate of 99 percent. But I wound up with every side effect you could receive.”
MINNEAPOLIS, MN - As Jim Valvano was accepting the Arthur Ashe Courage and Humanitarian Award at the inaugural ESPYS on March 4, 1993, he said “Don't Give Up . . . Don’t Ever Give Up!”® His words have inspired a generation, and the V Foundation for Cancer Research was born that night. The organization has since provided over $225 million in cancer research grants nationwide.
MINNEAPOLIS/ST. PAUL (1/18/2019) — Ovarian cancer research at the University of Minnesota takes another leap forward as two cancer research projects receive grants from the Department of Defense (DOD) office of the Congressionally Directed Medical Research Programs (CDMRP).
Funding allows further testing of genome editing technologies
MINNEAPOLIS, MN- January 18, 2019 - University of Minnesota researchers embark on work which could lead to a cure for some genetic diseases, such as cancer. Thanks to a U24 grant, part of the NIH Common Fund’s Somatic Cell Gene Editing (SCGE) consortium, Branden Moriarity, PhD, Assistant Professor in the Department of Pediatrics at the University of Minnesota Medical School and Masonic Cancer Center member, will begin to test genome editing technologies.